Teaching patients to use inhaled insulin. #Afrezza https://t.co/sdvcddIyOF
— LeAnne Rooks (@RooksLeAnne) April 21, 2021
Inhaled #Insulin: Reaching for the Stars in #PPG Control with Dr. Pettus, Dr. Bode, and Dr. McGill https://t.co/Fs7pGm5i2L pic.twitter.com/Ynln6LVEzp
— Medscape Education (@MedscapeCME) May 26, 2021
Excellent presentation! Note: registration with Medscape Education is free. It took me just one minute to register for an account.
One Step for Mannkind and a Huge Inhalation for People with Diabetes
Taking Control Of Your Diabetes / Published on Feb 7, 2021
https://twitter.com/johnhindepost/status/752789196125958144
Deciphering the Data on Inhaled Insulin: Implications for Practice
Deciphering the Data on Inhaled Insulin: Implications for Practice
(follow this embedded link if you have trouble getting to the video)
Super rapid acting insulin and inhaled Afrezza
Jay Skyler MD PhD discusses the prandial problem and the need for super rapid acting insulin, such as MannKind’s inhaled Afrezza
Ask Joslin: Inhalable Insulin
Dr. Robert Gabbay, Chief Medical Officer at Joslin Diabetes Center, answers some of your questions about the inhalable insulin on the market today.
Artificial Pancreas — Ultra-Rapid-Acting Inhaled Insulin
JDRF, Sansum Diabetes Research Institute, and the College of Engineering at University of California, Santa Barbara (UCSB) are pleased to announce the first successful clinical research trial using the artificial pancreas in conjunction with ultra-rapid-acting inhaled insulin.
Mannkind ADCOM public testimony
Apr 1-2014